Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Thursday's Pre-Market Session

 

Gainers

  • Intercept Pharmaceuticals (NASDAQ:ICPT) stock increased by 41.2% to $22.86 during Thursday's pre-market session. The market value of their outstanding shares is at $678.8 million.
  • Frequency Therapeutics (NASDAQ:FREQ) shares increased by 9.23% to $1.42. The market value of their outstanding shares is at $49.6 million. The company's, Q1 earnings came out yesterday.
  • GT Biopharma (NASDAQ:GTBP) shares rose 8.9% to $2.08. The market value of their outstanding shares is at $66.8 million.
  • Aeglea BioTherapeutics (NASDAQ:AGLE) shares increased by 8.32% to $1.69. The market value of their outstanding shares is at $83.5 million.
  • VYNE Therapeutics (NASDAQ:VYNE) shares increased by 8.05% to $0.48. The market value of their outstanding shares is at $27.6 million.
  • Marinus Pharma (NASDAQ:MRNS) stock moved upwards by 7.66% to $6.6. The company's market cap stands at $244.3 million.

Losers

  • AIkido Pharma (NASDAQ:AIKI) stock decreased by 13.9% to $0.4 during Thursday's pre-market session. The market value of their outstanding shares is at $35.5 million.
  • Kintara Therapeutics (NASDAQ:KTRA) shares declined by 10.85% to $0.24. The company's market cap stands at $15.7 million.
  • Aclarion (NASDAQ:ACON) shares decreased by 10.22% to $2.11. The market value of their outstanding shares is at $16.5 million.
  • Tempest Therapeutics (NASDAQ:TPST) stock decreased by 10.11% to $3.38. The company's market cap stands at $24.2 million.
  • Reshape Lifesciences (NASDAQ:RSLS) shares declined by 10.08% to $0.75. The market value of their outstanding shares is at $2.6 million.
  • Sonoma Pharmaceuticals (NASDAQ:SNOA) stock fell 8.22% to $3.13. The company's market cap stands at $9.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.